Federal award (DELIVERY ORDER, fiscal year 2023)
Recipient: DMS PHARMACEUTICAL GROUP INC
Awarding agency: Department of Defense / Defense Logistics Agency
Funding agency: Department of Defense / Defense Logistics Agency
Period of performance: 2023-12-28 to 2024-01-08
Current total value of award: $45.75
Description: 8510357607!MIDAZOLAM HYDROCHLO